$RTRX Travere Therapeutics, Inc. Insider Trading Week 20/2017
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Travere Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Travere Therapeutics, Inc. in week 20/2017.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 18 2017 | RTRX | Retrophin, Inc. | KOZARICH JOHN W | Director | Option Exercise | A | 17.44 | 10,000 | 174,400 | 10,000 | |
| May 18 2017 | RTRX | Retrophin, Inc. | KOZARICH JOHN W | Director | Grant | A | 0.00 | 2,500 | 0 | 24,500 | 22 K to 24.5 K (+11.36 %) |
| May 18 2017 | RTRX | Retrophin, Inc. | LYONS GARY A | Director | Option Exercise | A | 17.44 | 10,000 | 174,400 | 10,000 | |
| May 18 2017 | RTRX | Retrophin, Inc. | LYONS GARY A | Director | Grant | A | 0.00 | 2,500 | 0 | 26,500 | 24 K to 26.5 K (+10.42 %) |
| May 18 2017 | RTRX | Retrophin, Inc. | Meckler Jeffrey A | Director | Option Exercise | A | 17.44 | 10,000 | 174,400 | 10,000 | |
| May 18 2017 | RTRX | Retrophin, Inc. | Meckler Jeffrey A | Director | Grant | A | 0.00 | 2,500 | 0 | 56,500 | 54 K to 56.5 K (+4.63 %) |
| May 18 2017 | RTRX | Retrophin, Inc. | Baynes Roy D. | Director | Option Exercise | A | 17.44 | 10,000 | 174,400 | 10,000 | |
| May 18 2017 | RTRX | Retrophin, Inc. | Baynes Roy D. | Director | Grant | A | 0.00 | 2,500 | 0 | 6,500 | 4 K to 6.5 K (+62.50 %) |
| May 18 2017 | RTRX | Retrophin, Inc. | Coughlin Timothy P | Director | Option Exercise | A | 17.44 | 10,000 | 174,400 | 10,000 | |
| May 18 2017 | RTRX | Retrophin, Inc. | Coughlin Timothy P | Director | Grant | A | 0.00 | 2,500 | 0 | 24,500 | 22 K to 24.5 K (+11.36 %) |
| May 18 2017 | RTRX | Retrophin, Inc. | Clague Laura | Chief Financial Off ... | Option Exercise | A | 17.44 | 60,000 | 1,046,400 | 60,000 | |
| May 18 2017 | RTRX | Retrophin, Inc. | McFarlane Neil F. | Chief Operating Off ... | Option Exercise | A | 17.44 | 90,000 | 1,569,600 | 90,000 | |
| May 18 2017 | RTRX | Retrophin, Inc. | ASELAGE STEVE | Chief Executive Off ... | Option Exercise | A | 17.44 | 165,000 | 2,877,600 | 165,000 |